INBS (Intelligent Bio Solutions) Moat Score: 5/10 (As of Jul. 01, 2026)


INBS Intelligent Bio Solutions Inc INBS
44 GF Score
Price $2.23
GF Value $3.93
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Intelligent Bio Solutions Moat Score?

Intelligent Bio Solutions INBS -2.19% 44 Moat Score is 5 as of Jul. 01, 2026. GuruFocus rates INBS with a GF Score™ of 44/100 and a GF Value™ of $3.93 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 846 Medical Devices & Instruments companies, Intelligent Bio Solutions ranks better than 91.25% on this metric.

Intelligent Bio Solutions has the Moat Score of 5, which implies that the company might have Narrow Moat - Solid narrow moat.

Intelligent Bio Solutions has Narrow Moat: Intelligent Bio Solutions Inc has a solid narrow moat due to its proprietary technology and ongoing R&D efforts. While it has some intellectual property, the competitive landscape in biotech remains challenging, limiting its moat strength.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Intelligent Bio Solutions might have Narrow Moat - Solid narrow moat.

Intelligent Bio Solutions  (NAS:INBS) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Intelligent Bio Solutions Moat Score Related Terms

INBS vs ITOC, WOK, BMRA: Moat Score Comparison

For the Medical Devices subindustry, Intelligent Bio Solutions's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Intelligent Bio Solutions Moat Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Intelligent Bio Solutions's Moat Score distribution charts can be found below:

* The bar in red indicates where Intelligent Bio Solutions's Moat Score falls into.


INBS
44GF Score
Intelligent Bio Solutions Inc INBS
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 5 mean?
Intelligent Bio Solutions (INBS) has a Moat Score of 5 as of Jul. 01, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Intelligent Bio Solutions ranks #74 out of 846 companies in the Medical Devices & Instruments industry, placing it in the top 8.7%.
Is Intelligent Bio Solutions' Moat Score too high?
Intelligent Bio Solutions' current Moat Score is 5. Based on the distribution chart, Intelligent Bio Solutions ranks #74 out of 846 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Intelligent Bio Solutions has a GF Score™ of 44/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Intelligent Bio Solutions' Moat Score compare to ITOC and WOK?
According to the Medical Devices & Instruments industry distribution chart, Intelligent Bio Solutions ranks #74 out of 846 companies for Moat Score. This places Intelligent Bio Solutions in the top 9% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Devices & Instruments company?
A good Moat Score depends on the Medical Devices & Instruments industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Intelligent Bio Solutions's current Moat Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Intelligent Bio Solutions stock overvalued right now?
Based on GuruFocus' analysis, Intelligent Bio Solutions (INBS) is currently considered Possible Value Trap. The stock's GF Value™ is $3.93, compared to a current price of $2.23 — trading 43.3% below its estimated fair value. The current Moat Score is 5. Intelligent Bio Solutions' overall GF Score™ is 44/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Intelligent Bio Solutions (INBS), the current Moat Score is 5 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Intelligent Bio Solutions (INBS) Overvalued in 2026?

Based on GuruFocus' analysis, Intelligent Bio Solutions stock appears to be undervalued. The current stock price of $2.23 is trading 43.3% below its estimated GF Value™ of $3.93. GuruFocus considers Intelligent Bio Solutions to be Possible Value Trap.

Key valuation signals for INBS:

  • Moat Score: 5
  • GF Value™: $3.93 vs. price of $2.23 (43.3% below fair value)
  • GF Score™: 44/100 with 3 warning signs

No single metric tells the full story. See the INBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Intelligent Bio Solutions Business Description

Address 135 West, 41ST Street, 5th Floor, New York, NY, USA, 10036
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.
44GF Score

Get the complete analysis for INBS

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.23
Price
$3.93
GF Value